Cytoreductive nephrectomy (CN) of the primary tumor in the face of metastatic disease is part of a multimodality approach including systemic therapy that is based on evidence from randomized ...
The following is a summary of “Effect of postoperative normothermic intraperitoneal chemotherapy on the prognosis of MPM patients receiving CRS+HIPEC: a single-center case-control study,” published in ...
The phase 3 Shorespan-007 trial will compare bomedemstat with hydroxyurea in patients with treatment-naive essential ...
For most patients younger than age 60 with polycythemia vera (PV) who are not considered high risk, cytoreductive therapies are withheld despite being highly effective. 2 Commerce Drive Suite 100 ...
The involvement of 2 surgeons during cytoreductive debulking and bowel surgery in patients with epithelial ovarian cancer significantly reduces the rate of anastomotic leaks. Patients with ...
For example, a very intense treatment method called cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS ...
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...
He is also among a small cadre of surgeons proficient in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a highly advanced procedure in which heated chemotherapy is ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term overall survival (OS) data ...
in patients who have previously not received cytoreductive therapy. Patients are now being enrolled in the study called Shorespan-007. The study will enroll approximately 300 patients globally.